A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers

NCT00951873 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A
Haemophilia B
Healthy

Interventions

DRUG: activated recombinant human factor VII, long acting
DRUG: placebo
DRUG: activated recombinant human factor VII, long acting

Sponsor

Novo Nordisk A/S